Jeffrey L. Saver, MD, global principle investigator for SWIFT PRIME discusses the results of the study which he presented at the International Stroke Conference 2015 in Nashville. The trial was stopped early for efficacy and has the potential to provide new emergency therapy for patients with large vessel occlusion.